11:33:41 EDT Sun 16 Jun 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:DBV from 2018-06-15 to 2019-06-14 - 19 items News ReleasesIn The NewsOther
DateSymPriceTypeHeadline
2019-02-04 16:02DBVNews ReleaseDBV Technologies to Present Data on Epicutaneous Immunotherapy at AAAAI 2019
2019-02-01 01:32DBVNews ReleaseDBV Technologies to Present at the 8th Annual Leerink Partners Global Healthcare Conference
2019-01-03 01:32DBVNews ReleaseDBV Technologies Expands and Strengthens Leadership Team
2018-12-19 17:02DBVNews ReleaseDBV Technologies: DBV Technologies Provides Update on Viaskin Peanut for Children Four to 11 Years of Age
2018-12-12 01:32DBVNews ReleaseDBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018
2018-11-20 01:31DBVNews ReleaseDBV Technologies Presents Data at ACAAI 2018 on Investigational Viaskin Peanut for the Treatment of Peanut-Allergic Children
2018-11-16 01:32DBVNews ReleaseDBV Technologies Appoints Daniel Tass © as Chief Executive Officer
2018-11-09 01:32DBVNews ReleaseDBV Technologies to Present Data Further Supporting the Use of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy at the 2018 ACAAI Meeting
2018-10-30 02:32DBVNews ReleaseDBV Technologies Reports September 30, 2018 Cash Position
2018-10-26 01:32DBVNews ReleaseDBV Technologies Announces Initiation of Part B of Phase III Study in Peanut-Allergic Toddlers
2018-10-22 01:32DBVNews ReleaseDBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration
2018-09-25 01:32DBVNews ReleaseDBV Technologies to Present at the Cantor Global Healthcare Conference
2018-09-12 01:31DBVNews ReleaseDBV Technologies Announces Positive DSMB Review of Part A of Phase III Study in Peanut-Allergic Toddlers
2018-09-07 01:32DBVNews ReleaseDBV Technologies : Reports First Half 2018 Financial Results
2018-09-05 01:32DBVNews ReleaseDBV Technologies, Geneva University Hospitals and BioNet-Asia Presented Additional Phase I Data on the Use of an Investigational Epicutaneous Patch in Boosting Pertussis Vaccination at the ECI
2018-08-31 01:32DBVNews ReleaseDBV Technologies to Attend Upcoming Investor Conferences
2018-07-27 01:31DBVNews ReleaseDBV Technologies Reports June 30, 2018 Cash Position
2018-07-26 01:31DBVNews ReleaseDBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
2018-06-22 16:01DBVNews ReleaseDBV Technologies Announces Results of its 2018 Ordinary and Extraordinary General Meeting and the Appointment of Joan Schmidt as Executive Vice President, General Counsel